Inventor
NADZAN ALEX M
US18 patents
⚠️ This page may combine multiple inventors who share the name “NADZAN ALEX M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIGAND PHARM INC
7 patentsUS6218430B1Apr 17, 2001
Vitamin D3 mimics
LIGAND PHARM INC84 citations95
US6083977AJul 4, 2000
Trienoic retinoid compounds and methods
LIGAND PHARM INC20 citations92
US5721103AFeb 24, 1998
Trienoic retinoid compounds and methods
LIGAND PHARM INC35 citations92
US5770382AJun 23, 1998
Tricyclic retinoids, methods for their production and use
LIGAND PHARM INC40 citations91
US5770378AJun 23, 1998
Tricyclic retinoids, methods for their production and use
LIGAND PHARM INC45 citations91
US6545049B1Apr 8, 2003
Dimer-selective RXR modulators and methods for their use
LIGAND PHARM INC22 citations89
US5770383AJun 23, 1998
Tricyclic retinoids, methods for their production and use
LIGAND PHARM INC18 citations83
ABBOTT LAB
7 patentsUS5340802AAug 23, 1994
Peptide analog type-B CCK receptor ligands
ABBOTT LAB47 citations91
US5128346AJul 7, 1992
Derivatives of D-glutamic acid and D-aspartic acid
ABBOTT LAB32 citations90
US5270302ADec 14, 1993
Derivatives of tetrapeptides as CCK agonists
ABBOTT LAB23 citations89
US4250304AFeb 10, 1981
2-Deoxy-2-substituted fortimicin A and B and derivatives
ABBOTT LAB11 citations72
US4572907AFeb 25, 1986
High caloric product for I.V. administration
ABBOTT LAB4 citations62
US4432985AFeb 21, 1984
N-alkylated carboxylic acid derivatives as anti-convulsant agents
ABBOTT LAB2 citations62
US4220756ASep 2, 1980
Method of producing 3-O-demethylfortimicin B,4-N-alkylfortimicin B derivatives and related aminoglycoside antibiotics
ABBOTT LAB3 citations58